Quantcast Sciele Pharma Signs Agreement With Addrenex Pharmaceuticals To Develop And Market - Congoo
 
Web  |  Images  |  News
 
News HomeUSWorldBusinessFinanceIndustryTechnologyScienceMedia & AdvertisingPolitics/LawEntertainmentInternetHealthSportsCulture
Log In
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market
Have an interest in this Story?
Sign Up for Real-Time email updates
Healthcare Sales & Marketing Network  | July 07, 2008
ATLANTA--(HSMN NewsFeed)--Sciele Pharma, Inc. (NASDAQ:SCRX ) today announced that it has signed an exclusive agreement with Addrenex Pharmaceuticals, Inc. to develop and market ADX415, a novel patented, centrally-acting alpha adrenergic receptor agonist, specific to Alpha-2 receptors, for the treatm...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
David Hood David Hood
Director
Marketing/Public Relations
Martin P. Lee Martin P. Lee
Mr
Knowledge Management
  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.
Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.